| Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors YE Nikiforov, RR Seethala, G Tallini, ZW Baloch, F Basolo, ... JAMA oncology 2 (8), 1023-1029, 2016 | 1540 | 2016 |
| Overview of the 2022 WHO classification of thyroid neoplasms ZW Baloch, SL Asa, JA Barletta, RA Ghossein, CC Juhlin, CK Jung, ... Endocrine pathology 33 (1), 27-63, 2022 | 799 | 2022 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 717 | 2017 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 696 | 2016 |
| Overview of the 2022 WHO classification of neuroendocrine neoplasms G Rindi, O Mete, S Uccella, O Basturk, S La Rosa, LAA Brosens, S Ezzat, ... Endocrine pathology 33 (1), 115-154, 2022 | 597 | 2022 |
| Overview of the 2017 WHO classification of pituitary tumors O Mete, MB Lopes Endocrine pathology 28, 228-243, 2017 | 485 | 2017 |
| Overview of the 2022 WHO classification of pituitary tumors SL Asa, O Mete, A Perry, RY Osamura Endocrine pathology 33 (1), 6-26, 2022 | 381 | 2022 |
| From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal SL Asa, O Casar-Borota, P Chanson, E Delgrange, P Earls, S Ezzat, ... Endocrine-related cancer 24 (4), C5-C8, 2017 | 330 | 2017 |
| Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas O Mete, SL Asa, AJ Gill, N Kimura, RR de Krijger, A Tischler Endocrine pathology 33 (1), 90-114, 2022 | 274 | 2022 |
| Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation O Mete, SL Asa Modern Pathology 24 (12), 1545-1552, 2011 | 235 | 2011 |
| The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas H Nishioka, N Inoshita, O Mete, SL Asa, K Hayashi, A Takeshita, ... Endocrine pathology 26, 349-355, 2015 | 216 | 2015 |
| Biomarkers of aggressive pituitary adenomas O Mete, S Ezzat, SL Asa Journal of molecular endocrinology 49 (2), R69-R78, 2012 | 205 | 2012 |
| Overview of the 2022 WHO classification of adrenal cortical tumors O Mete, LA Erickson, CC Juhlin, RR de Krijger, H Sasano, M Volante, ... Endocrine pathology 33 (1), 155-196, 2022 | 203 | 2022 |
| International histopathology consensus for unilateral primary aldosteronism TA Williams, CE Gomez-Sanchez, WE Rainey, TJ Giordano, AK Lam, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 42-54, 2021 | 198 | 2021 |
| Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant … U Cho, O Mete, MH Kim, JS Bae, CK Jung Modern Pathology 30 (6), 810-825, 2017 | 197 | 2017 |
| Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma O Mete, MB Lopes, SL Asa The American journal of surgical pathology 37 (11), 1694-1699, 2013 | 192 | 2013 |
| Overview of the 2022 WHO classification of parathyroid tumors LA Erickson, O Mete, CC Juhlin, A Perren, AJ Gill Endocrine Pathology 33 (1), 64-89, 2022 | 184 | 2022 |
| The diagnosis and clinical significance of paragangliomas in unusual locations SL Asa, S Ezzat, O Mete Journal of clinical medicine 7 (9), 280, 2018 | 171 | 2018 |
| Clinicopathological correlations in pituitary adenomas O Mete, SL Asa Brain pathology 22 (4), 443-453, 2012 | 167 | 2012 |
| Epidemiology and biomarker profile of pituitary adenohypophysial tumors O Mete, A Cintosun, I Pressman, SL Asa Modern Pathology 31 (6), 900-909, 2018 | 161 | 2018 |
